Evicenter
MarkdownMedical informationP&T meetings
Saroglitazar

Primary biliary cholangitis

Manufacturer
Zydus Therapeutics
Last updated
79 sources

Section 6 of 6

References

79 sources

  1. AASLD (2018) (opens in a new tab)
  2. AASLD (2021) (opens in a new tab)
  3. Aghemo et al. (2026) (opens in a new tab)
  4. Alvaro et al. (2025) (opens in a new tab)
  5. ClinicalTrials.gov NCT03112681 (opens in a new tab)
  6. ClinicalTrials.gov NCT05133336 (opens in a new tab)
  7. ClinicalTrials.gov NCT06427395 (opens in a new tab)
  8. ClinicalTrials.gov NCT07216235 (opens in a new tab)
  9. Corpechot et al. (2018) (opens in a new tab)
  10. Dalekos et al. (2026) (opens in a new tab)
  11. EASL Congress (2026) (opens in a new tab)
  12. EASL-AASLD (2026) (opens in a new tab)
  13. Elman et al. (2010) (opens in a new tab)
  14. EU Clinical Trials Register EudraCT 2022-001634-10 (opens in a new tab)
  15. FDA (2025) (opens in a new tab)
  16. FDA IQIRVO prescribing information (opens in a new tab)
  17. FDA Orphan Drug Designations and Approvals (2021) (opens in a new tab)
  18. Gelhorn et al. (2025) (opens in a new tab)
  19. Gerussi et al. (2021) (opens in a new tab)
  20. Giannini et al. (2025) (opens in a new tab)
  21. Giri et al. (2019) (opens in a new tab)
  22. Gish et al. (2026) (opens in a new tab)
  23. GSK (2026) (opens in a new tab)
  24. Hirschfield et al. (2024) (opens in a new tab)
  25. Indiana University (opens in a new tab)
  26. Intercept Pharmaceuticals (2025) (opens in a new tab)
  27. Jain et al. (2015) (opens in a new tab)
  28. Jani et al. (2013) (opens in a new tab)
  29. Kanth et al. (2017) (opens in a new tab)
  30. Kowdley et al. (2024) (opens in a new tab)
  31. Kumar et al. (2026a) (opens in a new tab)
  32. Kumar et al. (2026b) (opens in a new tab)
  33. Lammers et al. (2014) (opens in a new tab)
  34. Lawitz et al. (2023) (opens in a new tab)
  35. Levy et al. (2025a) (opens in a new tab)
  36. Levy et al. (2025b) (opens in a new tab)
  37. Levy et al. (2025c) (opens in a new tab)
  38. Lin et al. (2024) (opens in a new tab)
  39. LIVDELZI prescribing information (2026) (opens in a new tab)
  40. Liver International (2025) (opens in a new tab)
  41. Martins et al. (2026a) (opens in a new tab)
  42. Martins et al. (2026b) (opens in a new tab)
  43. Mayo et al. (2023) (opens in a new tab)
  44. MedChemExpress (opens in a new tab)
  45. National Institute of Diabetes and Digestive and Kidney Diseases (2021) (opens in a new tab)
  46. National Institute of Diabetes and Digestive and Kidney Diseases definition and facts page (opens in a new tab)
  47. National Institute of Diabetes and Digestive and Kidney Diseases symptoms and causes page (opens in a new tab)
  48. Patel et al. (2018a) (opens in a new tab)
  49. Patel et al. (2018b) (opens in a new tab)
  50. Poey (2026) (opens in a new tab)
  51. Saeedian et al. (2025) (opens in a new tab)
  52. Schattenberg et al. (2026) (opens in a new tab)
  53. Shamseddine et al. (2026) (opens in a new tab)
  54. Sohal et al. (2026) (opens in a new tab)
  55. Tang et al. (2024) (opens in a new tab)
  56. Veeva Systems EPICS-III study page (opens in a new tab)
  57. Veeva Systems EPICS-IV study page (opens in a new tab)
  58. Veeva Systems EPICS-V study page (opens in a new tab)
  59. Veeva Systems SARO.23.002 study page (opens in a new tab)
  60. Veeva Systems SARO.24.003 study page (opens in a new tab)
  61. Vuppalanchi et al. (2020) (opens in a new tab)
  62. Vuppalanchi et al. (2021) (opens in a new tab)
  63. Vuppalanchi et al. (2022) (opens in a new tab)
  64. Vuppalanchi et al. (2025) (opens in a new tab)
  65. Vuppalanchi et al. (2026) (opens in a new tab)
  66. You et al. (2023) (opens in a new tab)
  67. Zhao et al. (2026) (opens in a new tab)
  68. Zydus Lifesciences (2020) (opens in a new tab)
  69. Zydus Lifesciences (2024) (opens in a new tab)
  70. Zydus Lifesciences 19 May earnings call transcript (2026) (opens in a new tab)
  71. Zydus Lifesciences 4 November earnings call transcript (2026) (opens in a new tab)
  72. Zydus Lifesciences EVIDENCES-X topline results announcement (2026) (opens in a new tab)
  73. Zydus Lifesciences NDA priority review announcement (2026) (opens in a new tab)
  74. Zydus Therapeutics (2025) (opens in a new tab)
  75. Zydus Therapeutics (2026) (opens in a new tab)
  76. Zydus Therapeutics about us page (opens in a new tab)
  77. Zydus Therapeutics expanded access and compassionate use policy (opens in a new tab)
  78. Zydus Therapeutics PBC clinical trials page (opens in a new tab)
  79. Zydus Therapeutics pipeline page (opens in a new tab)